N. Anfossi, P. Andre, S. Guia, C. S. Falk, S. Roetynck et al., Human NK cell education by inhibitory receptors for MHC class I, Immunity, vol.25, pp.331-342, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00091535

H. De-la-salle, D. Hanau, D. Fricker, A. Urlacher, A. Kelly et al., Homozygous human TAP peptide transporter mutation in HLA class I de ciency, Science, vol.265, pp.237-241, 1994.

M. Carrington and M. P. Martin, The impact of variation at the KIR gene cluster on human disease, Curr. Top. Microbiol. Immunol, vol.298, pp.225-257, 2006.

E. Mortier, T. Woo, R. Advincula, S. Gozalo, and A. Ma, IL-15R ? chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation, J. Exp. Med, vol.205, pp.1213-1225, 2008.

A. Ma, R. Koka, and P. Burkett, Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis, Annu. Rev. Immunol, vol.24, pp.657-679, 2006.

M. P. Rubinstein, M. Kovar, J. F. Purton, J. H. Cho, O. Boyman et al., Converting IL-15 to a superagonist by binding to soluble IL-15R { alpha }, Proc. Natl. Acad. Sci. USA, vol.103, pp.9166-9171, 2006.

T. A. Stoklasek, K. S. Schluns, and L. Lefrancois, Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo, J. Immunol, vol.177, pp.6072-6080, 2006.

R. H. Buckley, Molecular defects in human severe combined immunode ciency and approaches to immune reconstitution, Annu. Rev. Immunol, vol.22, pp.625-655, 2004.

K. C. Gilmour, H. Fujii, T. Cranston, E. G. Davies, C. Kinnon et al., Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-de cient form of severe combined immunode ciency, Blood, vol.98, pp.877-879, 2001.

R. Gimeno, K. Weijer, A. Voordouw, C. H. Uittenbogaart, N. Legrand et al., Monitoring the e ect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2 ? / ? gammac ? / ? mice: functional inactivation of p53 in developing T cells, Blood, vol.104, pp.3886-3893, 2004.

E. Traggiai, L. Chicha, L. Mazzucchelli, L. Bronz, J. C. Pi-aretti et al., Development of a human adaptive immune system in cord blood cell-transplanted mice, Science, vol.304, pp.104-107, 2004.

N. D. Huntington, Y. Xu, S. L. Nutt, and D. M. Tarlinton, A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells, J. Exp. Med, vol.201, pp.1421-1433, 2005.

N. D. Huntington, H. Puthalakath, P. Gunn, E. Naik, E. M. Michalak et al., Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1, Nat. Immunol, vol.8, pp.856-863, 2007.

T. A. Fehniger and M. A. Caligiuri, Interleukin 15: biology and relevance to human disease, Blood, vol.97, pp.14-32, 2001.

E. Mortier, A. Quemener, P. Vusio, I. Lorenzen, Y. Boublik et al., Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins, J. Biol. Chem, vol.281, pp.1612-1619, 2006.

G. Bouchaud, L. Garrigue-antar, V. Sole, A. Quemener, Y. Boublik et al., The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-a nity binding and is crucial for the IL-15 antagonistic e ect of soluble IL-15Ralpha, J. Mol. Biol, vol.382, pp.1-12, 2008.

W. E. Carson, T. A. Fehniger, S. Haldar, K. Eckhert, M. J. Lindemann et al., A potential role for interleukin-15 in the regulation of human natural killer cell survival, J. Clin. Invest, vol.99, pp.937-943, 1997.

X. Zheng, Y. Wang, H. Wei, B. Ling, R. Sun et al., Bcl-xL is associated with the anti-apoptotic e ect of IL-15 on the survival of CD56(dim) natural killer cells, Mol. Immunol, vol.45, pp.2559-2569, 2008.

T. A. Fehniger, S. F. Cai, X. Cao, A. J. Bredemeyer, R. M. Presti et al., Acquisition of murine NK cell cytotoxicity 5 and 20 ng/ml, respectively. In vitro restimulation of HIS-derived NK cells was performed using CD56 + NK cells puri ed by magnetic beads (Miltenyi Biotech) from a cell suspension of spleen and bone marrow from seven HIS mice pooled together. NK cells were cultured at 2.5 × 10 5 cells/ml in RPMI supplemented with 10% FCS, p.15, 2007.

R. , Systems) or 2.5 × 10 6 K562 cells/ml (American Type Culture Collection) for 18 h

N. D. Huntington, C. A. Vosshenrich, and J. P. Di-santo, Developmental pathways that generate natural-killer-cell diversity in mice and humans, Nat. Rev. Immunol, vol.7, pp.703-714, 2007.

R. Jacobs, M. Stoll, G. Stratmann, R. Leo, H. Link et al., CD16-CD56+ natural killer cells after bone marrow transplantation, Blood, vol.79, pp.3239-3244, 1992.

L. R. Gottschalk, R. A. Bray, H. Kaizer, and H. M. Gebel, Two populations of CD56 (Leu-19)+/CD16+ cells in bone marrow transplant recipients, Bone Marrow Transplant, vol.5, pp.259-264, 1990.

A. Chan, D. L. Hong, A. Atzberger, S. Kollnberger, A. D. Filer et al., CD56bright human NK cells di erentiate into CD56dim cells: role of contact with peripheral broblasts, J. Immunol, vol.179, pp.89-94, 2007.

C. Romagnani, K. Juelke, M. Falco, B. Morandi, A. Agostino et al., CD56brightCD16-killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation, J. Immunol, vol.178, pp.4947-4955, 2007.

, requires the translation of a pre-existing pool of granzyme B and perforin mRNAs, Immunity, vol.26, pp.798-811

W. E. Carson, J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh et al., Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor, J. Exp. Med, vol.180, pp.1395-1403, 1994.

S. Cooley, F. Xiao, M. Pitt, M. Gleason, V. Mccullar et al., A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature, Blood, vol.110, pp.578-586, 2007.

J. Giron-michel, M. Giuliani, M. Fogli, D. Brouty-boye, S. Ferrini et al., Membrane-bound and soluble IL-15/IL-15Ralpha complexes display di erential signaling and functions on human hematopoietic progenitors, Blood, vol.106, pp.2302-2310, 2005.

A. C. Jaleco, A. P. Stegmann, M. H. Heemskerk, F. Couwenberg, A. Q. Bakker et al., Genetic modi cation of human B-cell development: B-cell development is inhibited by the dominant negative helix loop helix factor Id3, Blood, vol.94, pp.2637-2646, 1999.

M. H. Heemskerk, B. Blom, G. Nolan, A. P. Stegmann, A. Q. Bakker et al., Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3, J. Exp. Med, vol.186, pp.1597-1602, 1997.

T. M. Kinsella and G. P. Nolan, Episomal vectors rapidly and stably produce high-titer recombinant retrovirus, Hum. Gene Ther, vol.7, pp.1405-1413, 1996.